Merck's New LANEXO(TM) System to Improve Scientists' Productivity in the Lab

PR83101

DARMSTADT, Germany, Mar. 4, 2020 /PRNewswire=KYODO JBN/--

-  First-to-market digital laboratory informatics solution with RFID labels

  for rapid access to reagent data

-  Improves inventory management; facilitates regulatory compliance; minimizes

  reagent waste

-  Reduces time on repetitive, error-prone tasks

Merck, a leading science and technology company, today launched its LANEXO(TM)

Lab Inventory, Safety and Compliance Management System (

https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=2574861931&u=http%3A%2F%2Fwww.sigmaaldrich.com%2FLanexo&a=LANEXO%E2%84%A2+Lab+Inventory%2C+Safety+and+Compliance+Management+System

), a new digital laboratory informatics solution designed to drastically

reduce(1) time in labs and improve data quality and traceability.

Photo - https://mma.prnewswire.com/media/1096823/Merck_LANEXO.jpg

"Today, 85 percent of labs are using paper or Excel to manage consumables data,

and 25 percent of time is spent managing these data — taking scientists away

from bench research," said Jean-Charles Wirth, head of Applied Solutions, Life

Science at Merck. "Lab efficiency is critical as it gives scientists more time

to focus on their research and analytics work and less on administrative tasks,

which ultimately leads to faster drug development. Our LANEXO(TM) System — with

first-to-market features — underscores Merck's commitment to advancing and

commercializing laboratory informatics."

Laboratory informatics is the application of data using a platform of software,

data management tools and equipment that allow scientific data to be captured

and interpreted for immediate use, and then stored for future research and

development purposes. The laboratory informatics market, which accounted for

$2.4 billion in 2018, is expected to reach $5.45 billion by 2027, according to

a recent Research and Markets global market outlook report (

https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=2861032949&u=https%3A%2F%2Fwww.researchandmarkets.com%2Freports%2F4897418%2Flaboratory-informatics-global-market-outlook%3Futm_source%3Ddynamic%26utm_medium%3DBW%26utm_code%3Dbt25ps%26utm_campaign%3D1341235%2B-%2BGlobal%2BLaboratory%2BInformatics%2BMarkets%2BExpected%2Bto%2BGrow%2Bwith%2Ba%2BCAGR%2Bof%2B9.5%2525%2BDuring%2Bthe%2BForecast%2BPeriod%252c%2B2018-2027%26utm_exec%3Danwr281bwd&a=Research+and+Markets+global+market+outlook+report

).  

Merck is the first to offer radio-frequency identification (RFID) labels which

auto-register open dates and calculate expiry dates. Through this digital data

capture, the LANEXO(TM) System rapidly documents lab reagent data in real time.

Digitalized inventory, expiration and storage monitoring reduces human error

and safety risks and improves the reliability and traceability of compliance

documentation. Ultimately, each reagent, including in-house preparations, can

be instantly matched to a full audit report. Within an experimental workflow,

the system allows for easy reagent identity checks and provides automatic

alerts, helping scientists to avoid using expired reagents and minimizing

experimental error.

The cloud-based LANEXO(TM) System can be easily set up and rapidly integrated

into existing lab workflows. It includes mobile (Android) and web applications

and is designed for use in highly regulated analytical and research labs in

pharmaceutical, quality assurance / quality control and industrial testing

markets.

Merck last year launched Milli-Q(R) Connect (

https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=3080595286&u=https%3A%2F%2Fwww.sigmaaldrich.com%2Ftechnical-documents%2Farticles%2Fbiology%2Fwater-purification-systems%2Fafs-e-high-throughput.html&a=Milli-Q%C2%AE+Connect

), a cloud-based service portal for its water purification systems, and also

acquired BSSN Software, a lab informatics company that makes data more readily

accessible for ease of integration, collaboration, analysis and long-term

archiving.

Merck unveiled the LANEXO(TM) System during a press conference at the Pittcon

Conference & Expo 2020 (

https://c212.net/c/link/?t=0&l=en&o=2733549-2&h=1602581360&u=http%3A%2F%2Fpittcon.org%2F&a=Pittcon+Conference+%26+Expo+2020

) in Chicago, Illinois, USA. The system is an expansion of Merck's portfolio of

digital lab productivity solutions. For more information, visit

www.SigmaAldrich.com/Lanexo.

All Merck news releases are distributed by email at the same time they become

available on the Merck website. Please go to www.merckgroup.com/subscribe to

register online, change your selection or discontinue this service.

About Merck

Merck, a leading science and technology company, operates across healthcare,

life science and performance materials. Around 56,000 employees work to make a

positive difference to millions of people's lives every day by creating more

joyful and sustainable ways to live. From advancing gene- editing technologies

and discovering unique ways to treat the most challenging diseases to enabling

the intelligence of devices – Merck is everywhere. In 2018, Merck generated

sales of €14.8 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to

Merck's technological and scientific advances. This is how Merck has thrived

since its founding in 1668. The founding family remains the majority owner of

the publicly listed company. Merck holds the global rights to the "Merck" name

and brand. The only exceptions are the United States and Canada, where the

business sectors operate as EMD Serono in healthcare, MilliporeSigma in life

science, and EMD Performance Materials.

(1) Merck estimates that its LANEXO(TM) System provides a 97 percent time

savings on inventory management and a 92 percent time savings on setting up an

experiment and documentation.

SOURCE:  Merck

CONTACT: karen.tiano@milliporesigma.com

         Phone: +49-6151-72-44461